ClinicalTrialsFinder
RecruitingNot ApplicableNCT07568015

ReneuRx™ (Nerve Selective Therapy) Utilized in Lateral Hip Pain

ReneuRx™ (Nerve Selective Therapy) Utilized in Lateral Hip Pain: A Multi-Center, Randomized, Controlled Trial (RENEU)

Sponsor

Brixton Biosciences, Inc.

Enrollment

100 participants

Start Date

Jul 27, 2026

Study Type

INTERVENTIONAL

Conditions

greater trochanteric pain syndromeLateral hip painGreater Trochanteric Pain Syndrome of Both Lower Limbs

Summary

The goal of this clinical trial is to evaluate the safety and analgesic performance of the ReneuRx™ device in subjects with moderate to severe chronic lateral hip pain compared to subjects receiving treatment with corticosteroid injection in adults aged 22-80 years. Participants will attend study visits and complete quality of life questionnaires. Participants will be followed for approximately 6-12 months after the study procedure.

Eligibility

Min Age: 22 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called ReneuRx and a drug called Triamcinolone acetate for people with greater trochanteric pain syndrome of both lower limbs, lateral hip pain, and other related conditions. The study is currently recruiting participants at 11 locations. People eligible for this study include aged 22 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGTriamcinolone acetate

A single 40mg Triamcinolone dose, prepared as 1ml of steroid mixed with 4ml of saline, of which 3-5ml is injected.

DEVICEReneuRx

ReneuRx will be injected around the trochanteric branches of the femoral nerve.

Locations(11)

Healthcare Outcomes Performance Company

Sun City, Arizona, United States

Emory Orthopedics and Spine Center

Johns Creek, Georgia, United States

Ochsner Health Center

New Orleans, Louisiana, United States

Skylight Health Research

Burlington, Massachusetts, United States

Mass General Brigham

Chestnut Hill, Massachusetts, United States

Virtua Health

Sewell, New Jersey, United States

The Orthopaedic Center

Tulsa, Oklahoma, United States

Rothman Orthopaedics

King of Prussia, Pennsylvania, United States

Pain Diagnostics & Interventional Care

Sewickley, Pennsylvania, United States

University of Texas Southwestern Medical Center

Dallas, Texas, United States

All-American Orthopedic & Sports

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07568015

Related Trials

HILT in Greater Trochanteric Pain Syndrome

NCT07749066

Evaluation of TENEX for Greater Trochanteric Pain Syndrome (GTPS)

NCT057106271 location

ESWT vs Conventional Physical Therapy in Greater Trochanteric Pain Syndrome

NCT072433271 location

Exercise and Patient Education for Patients With Lateral Hip Pain

NCT064182171 location

Ultrasound-Guided Percutaneous Neuromodulation on the Superior Gluteal Nerve in Patients With Greater Trochanteric Pain Syndrome: A Pilot Study

NCT065297831 location